Medications & Supplements/Prescription Drugs

Accord Healthcare Levothyroxine Sodium Tablets Recalled for Subpotency

Agency Publication Date: July 14, 2025

Summary

Accord Healthcare, Inc. is recalling 160,638 bottles of Levothyroxine Sodium Tablets, USP (the generic version of Synthroid) because the medication was found to be subpotent. This means the tablets contain less active medicine than what is listed on the label, which could lead to ineffective treatment of thyroid conditions. The recall affects seven different strengths and bottle sizes of the prescription medication distributed nationwide.

Risk

If the medication is subpotent, patients may receive a lower dose of thyroid hormone than their doctor intended. This can lead to symptoms of hypothyroidism (underactive thyroid) returning or worsening, which may require medical adjustment.

What You Should Do

This recall affects various strengths of Levothyroxine Sodium Tablets, USP (25 mcg, 50 mcg, 100 mcg, 112 mcg, 150 mcg, and 175 mcg) sold in 90-count and 1,000-count bottles under the Accord Healthcare, Inc. brand.
Check your prescription bottle for NDC codes 16729-447-17, 16729-447-15, 16729-448-15, 16729-451-17, 16729-452-17, 16729-455-17, or 16729-456-17. See the Affected Products section below for the full list of affected codes.
Check the lot number and expiration date on your bottle. Affected lot numbers include D2400679, D2300325, D2400536, D2300087, D2300092, D2400722, D2300104, D2300076, and D2300042, with expiration dates between December 2025 and March 2026.
If you have health concerns or notice your symptoms returning, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Accord Healthcare, Inc. directly for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 25 mcg (0.025 mg), Tablet

Lot Numbers:

D2400679 (Exp 02/28/2026)

NDC:

16729-447-17

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (90-count bottle)

Variants: 25 mcg (0.025 mg), Tablet

Lot Numbers:

D2300325 (Exp 01/31/2026)

D2400536 (Exp 02/28/2026)

NDC:

16729-447-15

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (90-count bottle)

Variants: 50 mcg (0.05 mg), Tablet

Lot Numbers:

D2300087 (Exp 12/31/2025)

NDC:

16729-448-15

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 100 mcg (0.1 mg), Tablet

Lot Numbers:

D2300092 (Exp 12/31/2025)

D2400722 (Exp 03/31/2026)

NDC:

16729-451-17

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 112 mcg (0.112 mg), Tablet

Lot Numbers:

D2300104 (Exp 12/31/2025)

NDC:

16729-452-17

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 150 mcg (0.15 mg), Tablet

Lot Numbers:

D2300076 (Exp 12/31/2025)

NDC:

16729-455-17

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 175 mcg (0.175 mg), Tablet

Lot Numbers:

D2300042 (Exp 12/31/2025)

NDC:

16729-456-17

Manufactured by Intas Pharmaceuticals Limited.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 97103

Status: Active

Manufacturer: ACCORD HEALTHCARE, INC.

Sold By: Pharmacies

Manufactured In: India

Units Affected: 7 products (82,159 bottles; 2,352 bottles; 54,227 bottles; 9,739 bottles; 4,896 bottles; 4,921 bottles; 2,344 bottles)

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects various strengths of Levothyroxine Sodium Tablets, USP (25 mcg, 50 mcg, 100 mcg, 112 mcg, 150 mcg, and 175 mcg) sold in 90-count and 1,000-count bottles under the Accord Healthcare, Inc. brand.

Check your prescription bottle for NDC codes 16729-447-17, 16729-447-15, 16729-448-15, 16729-451-17, 16729-452-17, 16729-455-17, or 16729-456-17. See the Affected Products section below for the full list of affected codes.

Check the lot number and expiration date on your bottle. Affected lot numbers include D2400679, D2300325, D2400536, D2300087, D2300092, D2400722, D2300104, D2300076, and D2300042, with expiration dates between December 2025 and March 2026.

If you have health concerns or notice your symptoms returning, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Accord Healthcare, Inc. directly for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 25 mcg (0.025 mg), Tablet

Lot Numbers:

D2400679 (Exp 02/28/2026)

NDC:

16729-447-17

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (90-count bottle)

Variants: 25 mcg (0.025 mg), Tablet

Lot Numbers:

D2300325 (Exp 01/31/2026)

D2400536 (Exp 02/28/2026)

NDC:

16729-447-15

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (90-count bottle)

Variants: 50 mcg (0.05 mg), Tablet

Lot Numbers:

D2300087 (Exp 12/31/2025)

NDC:

16729-448-15

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 100 mcg (0.1 mg), Tablet

Lot Numbers:

D2300092 (Exp 12/31/2025)

D2400722 (Exp 03/31/2026)

NDC:

16729-451-17

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 112 mcg (0.112 mg), Tablet

Lot Numbers:

D2300104 (Exp 12/31/2025)

NDC:

16729-452-17

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 150 mcg (0.15 mg), Tablet

Lot Numbers:

D2300076 (Exp 12/31/2025)

NDC:

16729-455-17

Manufactured by Intas Pharmaceuticals Limited.

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)

Variants: 175 mcg (0.175 mg), Tablet

Lot Numbers:

D2300042 (Exp 12/31/2025)

NDC:

16729-456-17

Manufactured by Intas Pharmaceuticals Limited.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 97103

Status: Active

Manufacturer: ACCORD HEALTHCARE, INC.

Sold By: Pharmacies

Manufactured In: India

Units Affected: 7 products (82,159 bottles; 2,352 bottles; 54,227 bottles; 9,739 bottles; 4,896 bottles; 4,921 bottles; 2,344 bottles)

Distributed To: Nationwide